Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells

Cellular thyroid hormone uptake and efflux are mediated by transmembrane transport proteins. One of these, monocarboxylate transporter 8 (MCT8) is mutated in Allan‐Herndon‐Dudley syndrome, a severe mental retardation associated with abnormal thyroid hormone constellations. Since mice deficient in Mc...

Full description

Saved in:
Bibliographic Details
Published inGlia Vol. 59; no. 3; pp. 463 - 471
Main Authors Braun, Doreen, Kinne, Anita, Bräuer, Anja U., Sapin, Remy, Klein, Marc O., Köhrle, Josef, Wirth, Eva K., Schweizer, Ulrich
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.03.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cellular thyroid hormone uptake and efflux are mediated by transmembrane transport proteins. One of these, monocarboxylate transporter 8 (MCT8) is mutated in Allan‐Herndon‐Dudley syndrome, a severe mental retardation associated with abnormal thyroid hormone constellations. Since mice deficient in Mct8 exhibit a milder neurological phenotype than patients, we hypothesized that alternative thyroid hormone transporters may compensate in murine brain cells for the lack of Mct8. Using qPCR, Western Blot, and immunocytochemistry, we investigated the expression of three different thyroid hormone transporters, i.e., Mct8 and L‐type amino acid transporters Lat1 and Lat2, in mouse brain. All three thyroid hormone transporters are expressed from corticogenesis and peak around birth. Primary cultures of neurons and astrocytes express Mct8, Lat1, and Lat2. Microglia specifically expresses Mct10 and Slco4a1 in addition to high levels of Lat2 mRNA and protein. As in vivo, a brain microvascular endothelial cell line expressed Mct8 and Lat1. 158N, an oligodendroglial cell line expressed Mct8 protein, consistent with delayed myelination in MCT8‐deficient patients. Functional T3‐ and T4‐transport assays into primary astrocytes showed KM values of 4.2 and 3.7 μM for T3 and T4. Pharmacological inhibition of L‐type amino acid transporters by BCH and genetic inactivation of Lat2 reduced astrocytic T3 uptake to the same extent. BSP, a broad spectrum inhibitor, including Mct8, reduced T3 uptake further suggesting the cooperative activity of several T3 transporters in astrocytes. © 2010 Wiley‐Liss, Inc.
Bibliography:ark:/67375/WNG-L9CWFRMK-P
Deutsche Forschungsgemeinschaft Sonderforschungsbereich - No. SFB 665
ArticleID:GLIA21116
istex:14EC22A3BF6A6D23EAEB433459BEE963CE64C5CA
Eva K. Wirth and Ulrich Schweizer contributed equally to this work.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0894-1491
1098-1136
1098-1136
DOI:10.1002/glia.21116